How Value Analysis Committees’ Lines of Questioning Can Directly Affect Value Equation Outputs

By AHRMM

John Kelty from W.L. Gore & Associates discusses how value analysis committees can determine a medical devices value when evaluating new products. 

Related Resources

Case Studies
Leading Practice: Reduction or Elimination of CAUTI - Saint Clare's Health System
AHRMM is offering a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Case Studies
Leading Practice: Reduction or Elimination of CAUTI - University of Virginia Health System
AHRMM is developing a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Case Studies
Leading Practice: Reduction or Elimination of HAPU - Nexera
The following leading practice describes methods used to reduce Hospital Acquired Pressure Ulcers (HAPU).
Case Studies
Leading Practice: Reduction or Elimination of HAPU - University of Virginia Health System
AHRMM is developing a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Senior Contract Specialist
Senior Contract Specialist job description.
Advisory
UDI and Adverse Event Reporting Advisory
The Food and Drug Administration (FDA) UDI system is being phased in over several years.